PARD — Poniard Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$0.34m
Annual cashflow statement for Poniard Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2006 December 31st | 2007 December 31st | 2008 December 31st | 2009 December 31st | 2010 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -23.3 | -32.8 | -48.6 | -45.7 | -30.1 |
| Depreciation | |||||
| Non-Cash Items | 5.33 | 4.97 | 7.5 | 11.3 | 11.3 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.087 | 1.63 | 5.97 | -2.51 | -6.85 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -17.3 | -24.7 | -33.5 | -35.5 | -24.3 |
| Capital Expenditures | -5.38 | -5.77 | -0.391 | -0.021 | -0.007 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -9.45 | -49.8 | 34.7 | 1.18 | 24 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -14.8 | -55.5 | 34.3 | 1.16 | 24 |
| Financing Cash Flow Items | 0.856 | -0.145 | -0.2 | 0 | 0.123 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 72.7 | 65.4 | 14 | 6.13 | -14.4 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 40.6 | -14.8 | 14.8 | -28.2 | -14.7 |